FDMT 8-K 2026-06-22

4D Molecular Therapeutics, Inc. (FDMT) 8-K dated 2026-06-22 — accession 0001193125-26-277563. This URL is the filing, not the FDMT hub.

4D Molecular Therapeutics, Inc. (FDMT) is a biotechnology company listed on US.

4D Molecular Therapeutics, Inc. filed a 8-K on 2026-06-22. Accession 0001193125-26-277563.

Cached items: 5.07. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported FDMT revenue for 2025-12-31 was $85.2M. Net income was -$140.1M. Revenue was up 230194.6% from 2024-12-31 to 2025-12-31. FDMT currently screens at market cap $518.1M.

Not investment advice. The FDMT SEC hub lists recent forms. The stock page is the research view.